Caroline Baumal - Net Worth and Insider Trading
Caroline Baumal Net Worth
The estimated net worth of Caroline Baumal is at least $963,561 dollars as of 2024-11-13. Caroline Baumal is the Chief Medical Officer of Apellis Pharmaceuticals Inc and owns about 32,931 shares of Apellis Pharmaceuticals Inc (APLS) stock worth over $963,561. Details can be seen in Caroline Baumal's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Caroline Baumal has not made any transactions after 2024-01-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Caroline Baumal
Caroline Baumal Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Caroline Baumal owns 1 companies in total, including Apellis Pharmaceuticals Inc (APLS) .
Click here to see the complete history of Caroline Baumal’s form 4 insider trades.
Insider Ownership Summary of Caroline Baumal
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2024-01-04 | Chief Medical Officer |
Caroline Baumal Latest Holdings Summary
Caroline Baumal currently owns a total of 1 stock. Caroline Baumal owns 32,931 shares of Apellis Pharmaceuticals Inc (APLS) as of January 4, 2024, with a value of $963,561.
Latest Holdings of Caroline Baumal
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2024-01-04 | 32,931 | 29.26 | 963,561 |
Holding Weightings of Caroline Baumal
Caroline Baumal Form 4 Trading Tracker
According to the SEC Form 4 filings, Caroline Baumal has made a total of 1 transactions in Apellis Pharmaceuticals Inc (APLS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Apellis Pharmaceuticals Inc is the sale of 2,751 shares on January 4, 2024, which brought Caroline Baumal around $165,198.
Insider Trading History of Caroline Baumal
- 1
Caroline Baumal Trading Performance
Caroline Baumal Ownership Network
Ownership Network List of Caroline Baumal
Ownership Network Relation of Caroline Baumal
Caroline Baumal Owned Company Details
What does Apellis Pharmaceuticals Inc do?
Who are the key executives at Apellis Pharmaceuticals Inc?
Caroline Baumal is the Chief Medical Officer of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Chief Financial Officer Timothy Eugene Sullivan .
Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary
Over the past 18 months, Caroline Baumal made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 296,688 shares made by Pascal Deschatelets , a net sale of 463,087 shares made by Cedric Francois , and a net sale of 102,839 shares made by Timothy Eugene Sullivan .
In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,263,451 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,263,451 shares.
Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apellis Pharmaceuticals Inc Insider Transactions
Caroline Baumal Mailing Address
Above is the net worth, insider trading, and ownership report for Caroline Baumal. You might contact Caroline Baumal via mailing address: C/o Apellis Pharmaceuticals, Inc., 100 5th Avenue, 3rd Floor, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
